Table 3

Clinical characteristics of the patients with a high iron score and treatment-related death AML indicates acute myeloid leukemia

Demographics

Disease

Donor

Conditioning

Iron Score (pRBCs)

Survival

Cause of Death


53 y/o male

ALL (CR2)

MRD

Cytoxan/TBI

2 (45)

16 days

Clostridial sepsis

24 y/o female

AML (CR1)

MUD

Busulfan/Cytoxan

2 (42)

26 days

Septic shock (culture negative)

48 y/o female

AML (CR2)

MRD

Cytoxan/TBI

3 (38)

8 days

Pneumonia/ARDS

62 y/o female

Refractory AML

MRD

Non-ablative

2 (43)

50 days

CMV pneumonia

50 y/o female

MDS

MUD

Cytoxan/TBI

3 (35)

6 days

Pneumonia/ARDS

32 y/o male

AML (CR1)

MRD

Cytoxan/TBI

2 (58)

13 days

Septic shock (culture negative)

49 y/o female

Aplastic anemia

MUD

Cytoxan/TBI

2 (30)

27 days

Gram-negative sepsis


ALL, acute lymphoblastic leukemia; MDS myelodysplastic syndrome; MRD matched related donor; MUD matched unrelated donor; TBI total body irradiation; ARDS acute respiratory distress syndrome.

Storey et al. Journal of Hematology & Oncology 2009 2:44   doi:10.1186/1756-8722-2-44

Open Data